Tully KM - Search Results

1

Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer.

Pereira PMR, Mandleywala K, Monette S, Lumish M, Tully KM, Panikar SS, Cornejo M, Mauguen A, Ragupathi A, Keltee NC, Mattar M, Janjigian YY, Lewis JS. Pereira PMR, et al. Among authors: tully km. Nat Commun. 2022 May 9;13(1):2526. doi: 10.1038/s41467-022-30142-9. Nat Commun. 2022. PMID: 35534471 Free PMC article.

2

Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity.

Tully KM, Tendler S, Carter LM, Sharma SK, Samuels ZV, Mandleywala K, Korsen JA, Delos Reyes AM, Piersigilli A, Travis WD, Sen T, Pillarsetty N, Poirier JT, Rudin CM, Lewis JS. Tully KM, et al. Clin Cancer Res. 2022 Apr 1;28(7):1391-1401. doi: 10.1158/1078-0432.CCR-21-1533. Clin Cancer Res. 2022. PMID: 35046060 Free PMC article.

3

Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers.

Meyer JP, Tully KM, Jackson J, Dilling TR, Reiner T, Lewis JS. Meyer JP, et al. Among authors: tully km. Bioconjug Chem. 2018 Feb 21;29(2):538-545. doi: 10.1021/acs.bioconjchem.8b00028. Epub 2018 Feb 9. Bioconjug Chem. 2018. PMID: 29378403 Free PMC article.

4

Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer.

Korsen JA, Gutierrez JA, Tully KM, Carter LM, Samuels ZV, Khitrov S, Poirier JT, Rudin CM, Chen Y, Morris MJ, Bodei L, Pillarsetty N, Lewis JS. Korsen JA, et al. Among authors: tully km. Proc Natl Acad Sci U S A. 2022 Jul 5;119(27):e2203820119. doi: 10.1073/pnas.2203820119. Epub 2022 Jun 27. Proc Natl Acad Sci U S A. 2022. PMID: 35759660 Free PMC article.

5

A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals.

Sharma SK, Lyashchenko SK, Park HA, Pillarsetty N, Roux Y, Wu J, Poty S, Tully KM, Poirier JT, Lewis JS. Sharma SK, et al. Among authors: tully km. Nucl Med Biol. 2019 Apr;71:32-38. doi: 10.1016/j.nucmedbio.2019.04.005. Epub 2019 May 3. Nucl Med Biol. 2019. PMID: 31128476 Free PMC article.

6

Improved synthesis of the bifunctional chelator p-SCN-Bn-HOPO.

Bhupathiraju NVSDK, Younes A, Cao M, Ali J, Cicek HT, Tully KM, Ponnala S, Babich JW, Deri MA, Lewis JS, Francesconi LC, Drain CM. Bhupathiraju NVSDK, et al. Among authors: tully km. Org Biomol Chem. 2019 Jul 17;17(28):6866-6871. doi: 10.1039/c9ob01068h. Org Biomol Chem. 2019. PMID: 31268109 Free PMC article.

7

Toward the Optimization of Click-Mediated Pretargeted Radioimmunotherapy.

Membreno R, Keinänen OM, Cook BE, Tully KM, Fung KC, Lewis JS, Zeglis BM. Membreno R, et al. Among authors: tully km. Mol Pharm. 2019 May 6;16(5):2259-2263. doi: 10.1021/acs.molpharmaceut.9b00062. Epub 2019 Apr 9. Mol Pharm. 2019. PMID: 30912951 Free PMC article.

8

An in Vivo Nanosensor Measures Compartmental Doxorubicin Exposure.

Harvey JD, Williams RM, Tully KM, Baker HA, Shamay Y, Heller DA. Harvey JD, et al. Among authors: tully km. Nano Lett. 2019 Jul 10;19(7):4343-4354. doi: 10.1021/acs.nanolett.9b00956. Epub 2019 Jun 18. Nano Lett. 2019. PMID: 31244242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters